1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency

Detalhes bibliográficos
Autor(a) principal: Linhares,Natália Duarte
Data de Publicação: 2016
Outros Autores: Freire,Maíra Cristina Menezes, Cardenas,Raony Guimarães Corrêa do Carmo Lisboa, Pena,Heloisa Barbosa, Lachlan,Katherine, Dallapiccola,Bruno, Bacino,Carlos, Delobel,Bruno, James,Paul, Thuresson,Ann-Charlotte, Annerén,Göran, Pena,Sérgio D. J.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Genetics and Molecular Biology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572016000300349
Resumo: Abstract Deletion-induced hemizygosity may unmask deleterious autosomal recessive variants and be a cause of the phenotypic variability observed in microdeletion syndromes. We performed complete exome sequencing (WES) analysis to examine this possibility in a patient with 1p13.2 microdeletion. Since the patient displayed clinical features suggestive of Noonan Syndrome (NS), we also used WES to rule out the presence of pathogenic variants in any of the genes associated with the different types of NS. We concluded that the clinical findings could be attributed solely to the 1p13.2 haploinsufficiency. Retrospective analysis of other nine reported patients with 1p13.2 microdeletions showed that six of them also presented some characteristics of NS. In all these cases, the deleted segment included the NRAS gene. Gain-of-function mutations of NRAS gene are causally related to NS type 6. Thus, it is conceivable that NRAS haploinsufficiency and gain-of-function mutations may have similar clinical consequences. The same phenomenon has been described for two other genes belonging to the Ras/MAPK pathway: MAP2K2 and SHOC2. In conclusion, we here report genotype-phenotype correlations in patients with chromosome 1p13.2 microdeletions and we propose that NRAS may be a critical gene for the NS characteristics in the patients.
id SBG-1_d7b4188cc89a2a2e3c90be3194038601
oai_identifier_str oai:scielo:S1415-47572016000300349
network_acronym_str SBG-1
network_name_str Genetics and Molecular Biology
repository_id_str
spelling 1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency1p13.2 deletionNoonan syndrome type 6NRAS geneRASopathyunmasking heterozygosityAbstract Deletion-induced hemizygosity may unmask deleterious autosomal recessive variants and be a cause of the phenotypic variability observed in microdeletion syndromes. We performed complete exome sequencing (WES) analysis to examine this possibility in a patient with 1p13.2 microdeletion. Since the patient displayed clinical features suggestive of Noonan Syndrome (NS), we also used WES to rule out the presence of pathogenic variants in any of the genes associated with the different types of NS. We concluded that the clinical findings could be attributed solely to the 1p13.2 haploinsufficiency. Retrospective analysis of other nine reported patients with 1p13.2 microdeletions showed that six of them also presented some characteristics of NS. In all these cases, the deleted segment included the NRAS gene. Gain-of-function mutations of NRAS gene are causally related to NS type 6. Thus, it is conceivable that NRAS haploinsufficiency and gain-of-function mutations may have similar clinical consequences. The same phenomenon has been described for two other genes belonging to the Ras/MAPK pathway: MAP2K2 and SHOC2. In conclusion, we here report genotype-phenotype correlations in patients with chromosome 1p13.2 microdeletions and we propose that NRAS may be a critical gene for the NS characteristics in the patients.Sociedade Brasileira de Genética2016-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572016000300349Genetics and Molecular Biology v.39 n.3 2016reponame:Genetics and Molecular Biologyinstname:Sociedade Brasileira de Genética (SBG)instacron:SBG10.1590/1678-4685-GMB-2016-0049info:eu-repo/semantics/openAccessLinhares,Natália DuarteFreire,Maíra Cristina MenezesCardenas,Raony Guimarães Corrêa do Carmo LisboaPena,Heloisa BarbosaLachlan,KatherineDallapiccola,BrunoBacino,CarlosDelobel,BrunoJames,PaulThuresson,Ann-CharlotteAnnerén,GöranPena,Sérgio D. J.eng2016-08-25T00:00:00Zoai:scielo:S1415-47572016000300349Revistahttp://www.gmb.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||editor@gmb.org.br1678-46851415-4757opendoar:2016-08-25T00:00Genetics and Molecular Biology - Sociedade Brasileira de Genética (SBG)false
dc.title.none.fl_str_mv 1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency
title 1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency
spellingShingle 1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency
Linhares,Natália Duarte
1p13.2 deletion
Noonan syndrome type 6
NRAS gene
RASopathy
unmasking heterozygosity
title_short 1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency
title_full 1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency
title_fullStr 1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency
title_full_unstemmed 1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency
title_sort 1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency
author Linhares,Natália Duarte
author_facet Linhares,Natália Duarte
Freire,Maíra Cristina Menezes
Cardenas,Raony Guimarães Corrêa do Carmo Lisboa
Pena,Heloisa Barbosa
Lachlan,Katherine
Dallapiccola,Bruno
Bacino,Carlos
Delobel,Bruno
James,Paul
Thuresson,Ann-Charlotte
Annerén,Göran
Pena,Sérgio D. J.
author_role author
author2 Freire,Maíra Cristina Menezes
Cardenas,Raony Guimarães Corrêa do Carmo Lisboa
Pena,Heloisa Barbosa
Lachlan,Katherine
Dallapiccola,Bruno
Bacino,Carlos
Delobel,Bruno
James,Paul
Thuresson,Ann-Charlotte
Annerén,Göran
Pena,Sérgio D. J.
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Linhares,Natália Duarte
Freire,Maíra Cristina Menezes
Cardenas,Raony Guimarães Corrêa do Carmo Lisboa
Pena,Heloisa Barbosa
Lachlan,Katherine
Dallapiccola,Bruno
Bacino,Carlos
Delobel,Bruno
James,Paul
Thuresson,Ann-Charlotte
Annerén,Göran
Pena,Sérgio D. J.
dc.subject.por.fl_str_mv 1p13.2 deletion
Noonan syndrome type 6
NRAS gene
RASopathy
unmasking heterozygosity
topic 1p13.2 deletion
Noonan syndrome type 6
NRAS gene
RASopathy
unmasking heterozygosity
description Abstract Deletion-induced hemizygosity may unmask deleterious autosomal recessive variants and be a cause of the phenotypic variability observed in microdeletion syndromes. We performed complete exome sequencing (WES) analysis to examine this possibility in a patient with 1p13.2 microdeletion. Since the patient displayed clinical features suggestive of Noonan Syndrome (NS), we also used WES to rule out the presence of pathogenic variants in any of the genes associated with the different types of NS. We concluded that the clinical findings could be attributed solely to the 1p13.2 haploinsufficiency. Retrospective analysis of other nine reported patients with 1p13.2 microdeletions showed that six of them also presented some characteristics of NS. In all these cases, the deleted segment included the NRAS gene. Gain-of-function mutations of NRAS gene are causally related to NS type 6. Thus, it is conceivable that NRAS haploinsufficiency and gain-of-function mutations may have similar clinical consequences. The same phenomenon has been described for two other genes belonging to the Ras/MAPK pathway: MAP2K2 and SHOC2. In conclusion, we here report genotype-phenotype correlations in patients with chromosome 1p13.2 microdeletions and we propose that NRAS may be a critical gene for the NS characteristics in the patients.
publishDate 2016
dc.date.none.fl_str_mv 2016-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572016000300349
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572016000300349
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1678-4685-GMB-2016-0049
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Genética
publisher.none.fl_str_mv Sociedade Brasileira de Genética
dc.source.none.fl_str_mv Genetics and Molecular Biology v.39 n.3 2016
reponame:Genetics and Molecular Biology
instname:Sociedade Brasileira de Genética (SBG)
instacron:SBG
instname_str Sociedade Brasileira de Genética (SBG)
instacron_str SBG
institution SBG
reponame_str Genetics and Molecular Biology
collection Genetics and Molecular Biology
repository.name.fl_str_mv Genetics and Molecular Biology - Sociedade Brasileira de Genética (SBG)
repository.mail.fl_str_mv ||editor@gmb.org.br
_version_ 1752122387073073152